The fragile foundation: K awards and the path to independence

The NIH K-type Career Development Awards are designed to foster early-career researchers and clinicians, advancing them towards productive academic careers, and serve as a crucial entry point for ECRs to transition to independent research. Even before the proposed cuts, ECRs faced significant challenges, including hypercompetition for research funding, which disproportionately impacted those early in their scientific careers. Financial pressures, such as increasing educational debt, stagnant salaries, and demanding clinical responsibilities, are known to make research careers less appealing for young researchers and clinician-researchers. K awards provide protected time for research through the provision of salary and minor budgets for training expenses and research costs. Despite requiring institutions to protect a minimum of 75% effort (50% for surgical fields), these awards often fail to cover the aggregate costs of salary and research expenses. Thus, institutions often have to invest internal resources to support trainees during this phase of their career development. But most do invest because data show that K awards have their intended impact: receipt of a K award is associated with a marked increase in the likelihood of securing a first independent NIH award and a larger number of R01 equivalent awards [Reference McCoy, Katz and Louden2–Reference Nikaj and Lund4].

The impending catastrophe: proposed fy 2026 budget cuts

The President’s budget request for FY 2026 proposes $27.5 billion for NIH, an approximately 40 percent reduction from the FY 2025 estimated level [Reference Ordner5]. This cut would bring NIH’s budget below its inflation-adjusted level at the beginning of its budget doubling effort (FY 1998–2003). Such a drastic reduction is projected to significantly reduce the number of new awards and overall success rates for the extramural research community. The budget estimates that success rates for Research Project Grants (RPGs) would plummet from 18.5% in FY 2024 to an estimated 7.3% in FY 2026. This decline would severely diminish the opportunities for K-awardees to transition to independent funding, making an already difficult journey nearly impossible and crippling the nation’s future research efforts by stifling the continued career development of our next generation of scientists.

Moreover, the proposed budget intends to:

• Eliminate several Institutes and Centers, including the National Institute of Nursing Research and the Fogarty International Center, under the rationale of “reforming NIH.”

• Implement a capped 15% rate for facilities and administrative (F&A) costs, a measure that institutions contend will further strain their capacity to support research.

• Eliminate $80 million in funding for extramural construction grants (C06 program) and drastically reduce administrative supplements, providing funds for only about 100 supplements compared to 3,400 in FY 2024.

• Eliminate the ability to study certain disease areas that do not align with the administration’s priority areas

These changes will directly impact the infrastructure and support systems vital for ECRs. With fewer new awards, a lower success rate, and reduced supplementary funding, the workforce of scientists and clinician-scientists will inevitably shrink, threatening the very future of biomedical innovation.

Exacerbated disparities and systemic vulnerabilities

The impact of these cuts will not be felt equally across the research landscape. Lessons from the COVID-19 pandemic have highlighted the differential implications for ECRs, particularly those from underrepresented groups [Reference Douglas, Settles and Cech6,Reference Cui, Ding and Zhu7]. During the pandemic, female faculty, those underrepresented in medicine and science (URiMS), and early-stage faculty experienced significant declines in research productivity. ECRs with childcare responsibilities, regardless of gender, saw a 17% decline in research time [Reference Myers, Tham and Yin8].

A broader “intersectionality” analysis demonstrates that respondents identifying with a greater number of underrepresented groups (women, LGBTQ, Black or African American, Hispanic or Latino) experienced more negative impacts on research productivity and mental health during the pandemic [Reference Douglas, Settles and Cech6]. This pattern suggests that the proposed NIH budget cuts will disproportionately harm these groups, exacerbating inequities and further undermining equal opportunity to be part of and to succeed within the scientific workforce.

Consequences for biomedical advancement and a call to action

A dwindling pipeline of researchers and clinicians-scientists, especially one that becomes less diverse, threatens the foundation of biomedical innovation and national health security. The aging of the biomedical workforce is already a concern, with the average age for receiving a first R01 award around 45. Further impediments to early-career progression risk losing a generation of promising investigators. Aggravating factors include the real possibility of exporting these talented scientists to other countries that are primed to offer them funds, space, and unfettered access to resources upon which they can build their careers.

To mitigate this impending crisis, sustained and increased investment in K awards and comprehensive support for ECRs are paramount. We echo the calls for action from various scientific bodies and experts, including:

• Expanded grant programs: Increase the pool of career development awards (K, T, F). Through the 21st Century Cures Act and National Academies of Sciences, Engineering, and Medicine (NASEM) recommendations, the NIH has been urged to support independent research among ECRs and expand career development awards.

• Increase grant salary caps: Adjust these so that they more closely reflect the salaries of early-career scientists

• Continued support of the NIH Loan Repayment Program (LRP): While relatively small in scope, the LRP has become increasingly important for ECRs to gain sufficient financial relief to allow them to accept academic roles with lower pay scales than the private sector. Continued support of this program is critical.

• Facilities & Administration (F&A): Increase the F&A rate for career development awards to align with R-level research grants, thereby improving the support that institutions can provide to ECRs.

• Targeted support for early-stage faculty: Provide funded grant extensions for early-stage faculty whose research is disrupted for family reasons, medical issues or recent changes to federal grantmaking. As part of this, address rigid age or time-since-training cutoffs for eligibility that disadvantage those who take parental leave or have other caregiving responsibilities.

• Enhanced mentorship and infrastructure: Increase financial support and infrastructure for K-awardees, recognizing that salary-matching initiatives help maintain ECRs in the pipeline and likely improve K-to-R01 conversion rates. Institutions should provide robust mentorship programs and support structures for grant writing and data analysis.

• Flexible and family-friendly policies: Create universal paid family and medical leave policies and allow flexible work schedules, recognizing the disproportionate caregiving burdens faced by women and URiMS individuals. Expand institutional investment in affordable, accessible childcare and eldercare provisions [Reference Davis, Meagher and Pomeroy9].

The proposed NIH budget cuts represent a critical juncture for biomedical research. While the NIH has articulated priorities for the Administration, including a focus on improving population health and chronic disease research, a drastically reduced budget will make achieving these goals incredibly challenging, particularly if the foundation of early-career research is destabilized. Without immediate intervention and sustained investment, the nation risks not only losing a generation of talented ECRs but also jeopardizing its leadership in medical innovation and its ability to respond effectively to future public health challenges. It is imperative that policymakers and institutional leaders recognize the long-term value of nurturing this critical pipeline and act decisively to avert this crisis.